Cargando…
Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/β-Catenin Pathway
Background: Drug resistance represents a major challenge for treating patients with colon cancer. Accumulating evidence suggests that Insulin-like growth factor (IGF)-associated signaling promotes colon tumorigenesis and cancer stemness. Therefore, the identification of agents, which can disrupt can...
Autores principales: | Wu, Szu-Yuan, Huang, Yan-Jiun, Tzeng, Yew-Min, Huang, Chi-Ying F., Hsiao, Michael, Wu, Alexander T.H., Huang, Tse-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209980/ https://www.ncbi.nlm.nih.gov/pubmed/30257507 http://dx.doi.org/10.3390/cancers10100353 |
Ejemplares similares
-
Selective apoptotic cell death effects of oral cancer cells treated with destruxin B
por: Huang Liu, Rosa, et al.
Publicado: (2014) -
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
por: Sandén, Carl, et al.
Publicado: (2013) -
The Metarhizium anisopliae Toxin, Destruxin A, Interacts with the SEC23A and TEME214 Proteins of Bombyx mori
por: Yin, Fei, et al.
Publicado: (2021) -
Effects of Destruxin A on Silkworm’s Immunophilins
por: Wang, Jingjing, et al.
Publicado: (2019) -
Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways
por: Huang, Lingli, et al.
Publicado: (2021)